Abstract |
Chronic granulomatous disease is a primary immunodeficiency, comprising five molecular defects, characterized by an impaired respiratory burst activity of myeloid cells. We are currently developing a gene therapy vector for the p47phox-deficient form of chronic granulomatous disease. Classic intracellular immunostaining of the cytoplasmic p47phox transgene product, however, interferes with respiratory burst activity. In this study we report a new system for measuring p47phox expression: A single open reading frame encoding the surface marker protein ΔLNGFR (truncated low-affinity nerve growth factor receptor) linked to the p47phox transgene by the 2A oligopeptide coexpression technology. Translation generates two discrete products: p47phox localizing to the cytoplasm and 'ΔLNGFR-2A' localizing to the cell surface. Six weeks after transplantation of transduced autologous hematopoietic stem cells into p47-/- mice, the intracellular p47phox fluorescence-activated cell sorting (FACS) signal intensities corresponded to surface ΔLNGFR staining in monocytes, B cells, T cells and Sca I+ bone marrow cells in vivo. The p47phox cleavage product restored nicotinamide adenine dinucleotide phosphate- oxidase activity in granulocytes differentiated from transduced p47phox-/- murine hematopoietic stem cells ex vivo, in murine granulocytes/monocytes in vivo, and in transduced human monocyte derived macrophages from p47phox-deficient chronic granulomatous disease patients. In conclusion, this new marker system allows highly efficient, indirect detection of cytoplasmic transgene products by FACS surface staining.
|
Authors | V Wohlgensinger, R Seger, M D Ryan, J Reichenbach, U Siler |
Journal | Gene therapy
(Gene Ther)
Vol. 17
Issue 10
Pg. 1193-9
(Oct 2010)
ISSN: 1476-5462 [Electronic] England |
PMID | 20445581
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- Receptors, Nerve Growth Factor
- NADPH Oxidases
- neutrophil cytosolic factor 1
|
Topics |
- Animals
- Biomarkers
(chemistry)
- Flow Cytometry
- Genetic Therapy
- Genetic Vectors
(genetics)
- Granulomatous Disease, Chronic
(genetics, metabolism, therapy)
- Hematopoietic Stem Cells
(cytology, metabolism)
- Humans
- Mice
- NADPH Oxidases
(genetics, metabolism)
- Receptors, Nerve Growth Factor
(genetics)
- Transgenes
(genetics)
|